Clinical Trial Update: A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas [Phase 1]

View source ↗

Summary

Phase I study of intratumoral GC001 in patients with recurrent or progressive high-grade gliomas is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• GC001 (oncolytic vaccinia virus GC001)

Snippet

Sponsor: GONGCHU Biotechnology Co., Ltd | Conditions: High-grade Gliomas | Phase 1 | Status: RECRUITING